Abstract
Iron overload has recently been connected with bone mineral density in osteoporosis. However, to date, the effect of iron overload on osteoblasts remains poorly understood. The purpose of this study is to examine osteoblast biological activity under iron overload. The osteoblast cells (hFOB1.19) were cultured in a medium supplemented with different concentrations (50, 100, and 200 μM) of ferric ammonium citrate as a donor of ferric ion. Intracellular iron was measured with a confocal laser scanning microscope. Reactive oxygen species (ROS) were detected by 2,7-dichlorofluorescin diacetate fluorophotometry. Osteoblast biological activities were evaluated by measuring the activity of alkaline phosphatase (ALP) and mineralization function. Results indicated that iron overload could consequently increase intracellular iron concentration and intracellular ROS levels in a concentration-dependent manner. Additionally, ALP activity was suppressed, and a decline in the number of mineralized nodules was observed in in vitro cultured osteoblast cells. According to these results, it seems that iron overload probably inhibits osteoblast function through higher oxidative stress following increased intracellular iron concentrations.
Similar content being viewed by others
Abbreviations
- FAC:
-
Ferric ammonium citrate
- CLSM:
-
Confocal laser scanning microscope
- ROS:
-
Reactive oxygen species
- ALP:
-
Alkaline phosphatase
References
Ganz T (2009) Iron in innate immunity: starve the invaders. Curr Opin Immunol 21(1):63–67. doi:10.1016/j.coi.2009.01.011
MacKenzie EL, Iwasaki K, Tsuji Y (2008) Intracellular iron transport and storage: from molecular mechanisms to health implications. Antioxid Redox Signal 10(6):997–1030. doi:10.1089/ars.2007.1893
Li GF, Pan YZ, Sirois P, Li K, Xu YJ (2012) Iron homeostasis in osteoporosis and its clinical implications. Osteoporos Int J Established Result Coop Eur Found Osteoporos Natl Osteoporos Found USA. doi:10.1007/s00198-012-1982-1
Weinberg ED (2006) Iron loading: a risk factor for osteoporosis. Biometals Int J Role Met Ions Biol Biochem Med 19(6):633–635. doi:10.1007/s10534-006-9000-8
Guggenbuhl P, Fergelot P, Doyard M, Libouban H, Roth MP, Gallois Y, Chales G, Loreal O, Chappard D (2011) Bone status in a mouse model of genetic hemochromatosis. Osteoporos Int J Established Result Coop Eur Found Osteoporos Natl Osteoporos Found USA 22(8):2313–2319. doi:10.1007/s00198-010-1456-2
Guggenbuhl P, Brissot P, Loreal O (2011) Haemochromatosis: the bone and the joint. Best Pract Res Clin Rheumatol 25(5):649–664. doi:10.1016/j.berh.2011.10.014
Sarrai M, Duroseau H, D'Augustine J, Moktan S, Bellevue R (2007) Bone mass density in adults with sickle cell disease. Br J Haematol 136(4):666–672. doi:10.1111/j.1365-2141.2006.06487.x
Sadat-Ali M, Sultan O, Al-Turki H, AlElq A (2011) Does high serum iron level induce low bone mass in sickle cell anemia ? Biometals Int J Role Met Ions Biol Biochem Med 24(1):19–22. doi:10.1007/s10534-010-9391-4
Wibaux C, Legroux-Gerot I, Dharancy S, Boleslawski E, Declerck N, Canva V, Mathurin P, Pruvot FR, Cortet B (2011) Assessing bone status in patients awaiting liver transplantation. Joint Bone Spine 78(4):387–391. doi:10.1016/j.jbspin.2011.03.001
Loria I, Albanese C, Giusto M, Galtieri PA, Giannelli V, Lucidi C, Di Menna S, Pirazzi C, Corradini SG, Mennini G, Rossi M, Berloco P, Merli M (2010) Bone disorders in patients with chronic liver disease awaiting liver transplantation. Transplant Proc 42(4):1191–1193. doi:10.1016/j.transproceed.2010.03.096
Matsushima S, Hoshimoto M, Torii M, Ozaki K, Narama I (2001) Iron lactate-induced osteopenia in male Sprague–Dawley rats. Toxicol Pathol 29(6):623–629
Guggenbuhl P, Deugnier Y, Boisdet JF, Rolland Y, Perdriger A, Pawlotsky Y, Chales G (2005) Bone mineral density in men with genetic hemochromatosis and HFE gene mutation. Osteoporos Int J Established Result Coop Eur Found Osteoporos Natl Osteoporos Found USA 16(12):1809–1814. doi:10.1007/s00198-005-1934-0
Mahachoklertwattana P, Sirikulchayanonta V, Chuansumrit A, Karnsombat P, Choubtum L, Sriphrapradang A, Domrongkitchaiporn S, Sirisriro R, Rajatanavin R (2003) Bone histomorphometry in children and adolescents with beta-thalassemia disease: iron-associated focal osteomalacia. J Clin Endocrinol Metab 88(8):3966–3972
Isomura H, Fujie K, Shibata K, Inoue N, Iizuka T, Takebe G, Takahashi K, Nishihira J, Izumi H, Sakamoto W (2004) Bone metabolism and oxidative stress in postmenopausal rats with iron overload. Toxicology 197(2):93–100. doi:10.1016/j.tox.2003.12.006
Jian J, Pelle E, Huang X (2009) Iron and menopause: does increased iron affect the health of postmenopausal women? Antioxid Redox Signal 11(12):2939–2943. doi:10.1089/ARS.2009.2576
Jia P, Xu YJ, Zhang ZL, Li K, Li B, Zhang W, Yang H (2012) Ferric ion could facilitate osteoclast differentiation and bone resorption through the production of reactive oxygen species. J Orthop Res 30(11):1843–1852. doi:10.1002/jor.22133
Christenson RH (1997) Biochemical markers of bone metabolism: an overview. Clin Biochem 30(8):573–593
Finkel T, Holbrook NJ (2000) Oxidants, oxidative stress and the biology of ageing. Nature 408(6809):239–247. doi:10.1038/35041687
Zarjou A, Jeney V, Arosio P, Poli M, Zavaczki E, Balla G, Balla J (2010) Ferritin ferroxidase activity: a potent inhibitor of osteogenesis. J Bone Miner Res Off J Am Soc Bone Miner Res 25(1):164–172. doi:10.1359/jbmr.091002
Halliwell B, Gutteridge JM (1990) Role of free radicals and catalytic metal ions in human disease: an overview. Methods Enzymol 186:1–85
Fridovich I (1978) The biology of oxygen radicals. Science 201(4359):875–880
Hinoi E, Fujimori S, Wang L, Hojo H, Uno K, Yoneda Y (2006) Nrf2 negatively regulates osteoblast differentiation via interfering with Runx2-dependent transcriptional activation. J Biol Chem 281(26):18015–18024. doi:10.1074/jbc.M600603200
Bai XC, Lu D, Bai J, Zheng H, Ke ZY, Li XM, Luo SQ (2004) Oxidative stress inhibits osteoblastic differentiation of bone cells by ERK and NF-kappaB. Biochem Biophys Res Commun 314(1):197–207
Almeida M, Han L, Martin-Millan M, O'Brien CA, Manolagas SC (2007) Oxidative stress antagonizes Wnt signaling in osteoblast precursors by diverting beta-catenin from T cell factor- to forkhead box O-mediated transcription. J Biol Chem 282(37):27298–27305. doi:10.1074/jbc.M702811200
Tsay J, Yang Z, Ross FP, Cunningham-Rundles S, Lin H, Coleman R, Mayer-Kuckuk P, Doty SB, Grady RW, Giardina PJ, Boskey AL, Vogiatzi MG (2010) Bone loss caused by iron overload in a murine model: importance of oxidative stress. Blood 116(14):2582–2589. doi:10.1182/blood-2009-12-260083
Guggenbuhl P, Filmon R, Mabilleau G, Basle MF, Chappard D (2008) Iron inhibits hydroxyapatite crystal growth in vitro. Metab Clin Exp 57(7):903–910. doi:10.1016/j.metabol.2008.02.004
Yamasaki K, Hagiwara H (2009) Excess iron inhibits osteoblast metabolism. Toxicol Lett 191(2–3):211–215. doi:10.1016/j.toxlet.2009.08.023
Qu Z-H, Zhang X-L, Tang T-T, Dai K-R (2008) Promotion of osteogenesis through beta-catenin signaling by desferrioxamine. Biochem Bioph Res Co 370(2):332–337. doi:10.1016/j.bbrc.2008.03.092
Messer JG, Kilbarger AK, Erikson KM, Kipp DE (2009) Iron overload alters iron-regulatory genes and proteins, down-regulates osteoblastic phenotype, and is associated with apoptosis in fetal rat calvaria cultures. Bone 45(5):972–979. doi:10.1016/j.bone.2009.07.073
Acknowledgments
This work was partially supported by the National Natural Science Foundation of China (no. 81273090), Jiangsu provincial grant (no. BK2012608), and science and technology projects of Suzhou (no. 510303).
Author information
Authors and Affiliations
Corresponding author
Additional information
Yin-Feng He and Yong Ma contributed equally to this work.
Rights and permissions
About this article
Cite this article
He, YF., Ma, Y., Gao, C. et al. Iron Overload Inhibits Osteoblast Biological Activity Through Oxidative Stress. Biol Trace Elem Res 152, 292–296 (2013). https://doi.org/10.1007/s12011-013-9605-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12011-013-9605-z